Business & regional news

Month Year

Month Year

Dec 5, 2025

Medtronic appoints Ingrid Goldberg as vice president and head of investor relations; Ryan Weispfenning to join Diabetes to lead investor relations for MiniMed, the planned new diabetes company
- Corporate
- Diabetes
Dec 4, 2025

Medtronic earns FDA approval for expanded deep brain stimulation labeling for Dystonia

Now supported with effectiveness evidence, Medtronic DBS is the first and only U.S. FDA approved system to treat Dystonia symptoms
- Neuromodulation
Dec 3, 2025

Medtronic announces first procedure in Denmark using the Affera™ Mapping and Ablation System at Aarhus University Hospital
- Europe, Middle East & Africa
Dec 2, 2025

Medtronic welcomes Dr. Gerald Denny as Chief Medical Officer for Acute Care & Monitoring
- Acute Care & Monitoring
- Photos 1
Nov 25, 2025

Medtronic unveils Signia™ Circular stapler with Tri-Staple™ technology, bringing real-time intelligence and a new standard of precision to surgery
- Surgical
Nov 20, 2025

Medtronic Spark Scholarship launches to help students from low-income households globally pursue health tech careers
- Medtronic Foundation
Nov 14, 2025

Medtronic showcases AiBLE™ ecosystem advances at North American Spine Society’s (NASS) 40th Annual Meeting
- Cranial & Spinal Technologies
Nov 14, 2025

Medtronic Aurora EV-ICD™ system demonstrates exceptional results at six months in the Enlighten real-world post-market study while the OmniaSecure™ defibrillation lead sustains performance at three years in the LEADR Pivotal Trial

APHRS.25: Medtronic showcases breadth of defibrillation portfolio with outcomes from extravascular and transvenous defibrillation studies for the treatment of dangerous heart rhythm episodes
- Cardiac Rhythm Management
Nov 10, 2025

Application to confirm share capital reduction
- Corporate
Nov 10, 2025

Hypertension: renal denervation is now also available for patients with chronic kidney disease

Confirmation comes from the position paper published by the Italian Society of Nephrology (SIN), expanding the indication of RDN to a complex and high-risk patient population
- Europe, Middle East & Africa

Show per page